{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:45:14Z","timestamp":1792464314598,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Kidney involvement of visceral Leishmaniasis is previously reported, but knowledge is limited. Hypergammaglobulinemia is common in visceral leishmaniasis patients. Whether hypergammaglobulinemia after leishmaniasis depletion can cause kidney injury is not well reported yet.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We reported a patient who recovered from visceral Leishmaniasis but showed persistent hypergammaglobulinemia and elevated urinary protein. Kidney biopsy showed glomerular hypertrophy with mild segmental mesangial proliferation without tubulointerstitial involvement in light microscopy. No immune complex deposit was found in the mesangial area by neither immunofluorescent staining nor electronic microscope. Increased lysosomes were observed in proximal tubules by electronic microscope. Valsartan was administered to decrease urinary protein, and no immune-suppressive therapy was added. The urinary protein and serum IgG level gradually dropped, and serum creatinine level remained stable during three- month follow up.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Hypergammaglobulinemia is unlikely to cause renal structural or functional damage in the short term. Angiotensin blockade significantly reduced urine protein, with a minor effect on IgG elimination.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12879-021-05819-z","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T13:06:26Z","timestamp":1611839186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Continuous hypergammaglobulinemia and proteinuria after the recovery of the visceral Leishmaniasis: a case report"],"prefix":"10.1186","volume":"21","author":[{"given":"Linfeng","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9629-8320","authenticated-orcid":false,"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangzhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,28]]},"reference":[{"key":"5819_CR1","unstructured":"WHO Expert Committee on the Control of the Leishmaniases & World Health Organization: Control of the leishmaniases: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases. Geneva: World Health Organization; 2010."},{"key":"5819_CR2","doi-asserted-by":"crossref","unstructured":"Shamsian S, et al. Clinical and Laboratory Findings of Visceral Leishmaniasis in Children Hospitalized in Mashhad, Northeastern Iran: A Twenty-Year Retrospective Study. Iran J Parasitol. 2020;15(4):495\u20139.","DOI":"10.18502\/ijpa.v15i4.4854"},{"issue":"10","key":"5819_CR3","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1111\/tmi.13127","volume":"23","author":"GC Meneses","year":"2018","unstructured":"Meneses GC, et al. Visceral leishmaniasis-associated nephropathy in hospitalised Brazilian patients: new insights based on kidney injury biomarkers. Tropical Med Int Health. 2018;23(10):1046\u201357.","journal-title":"Tropical Med Int Health"},{"issue":"5","key":"5819_CR4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.5414\/CNP71492","volume":"71","author":"FAAL Verde","year":"2009","unstructured":"Verde FAAL, et al. Renal tubular dysfunction in human visceral Leishmaniasis (Kala-azar). Clin Nephrol. 2009;71(5):492\u2013500.","journal-title":"Clin Nephrol"},{"issue":"6","key":"5819_CR5","doi-asserted-by":"publisher","first-page":"370","DOI":"10.5414\/CN108195","volume":"83","author":"M Ortiz","year":"2015","unstructured":"Ortiz M, et al. Glomerulonephritis and cryoglobulinemia: first manifestation of visceral Leishmaniasis. Clin Nephrol. 2015;83(6):370\u20137.","journal-title":"Clin Nephrol"},{"issue":"4","key":"5819_CR6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/0035-9203(83)90131-1","volume":"77","author":"MI Duarte","year":"1983","unstructured":"Duarte MI, et al. Interstitial nephritis in human kala-azar. Trans R Soc Trop Med Hyg. 1983;77(4):531\u20137.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"5819_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0272-6386(85)80034-2","volume":"6","author":"M Dutra","year":"1985","unstructured":"Dutra M, et al. Renal involvement in visceral Leishmaniasis. Am J Kidney Dis. 1985;6(1):22\u20137.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"5819_CR8","first-page":"179","volume":"25","author":"V Chaigne","year":"2004","unstructured":"Chaigne V, et al. A patient with visceral Leishmaniasis and acute renal failure in necrotizing glomerulonephritis. Nephrologie. 2004;25(5):179\u201383.","journal-title":"Nephrologie"},{"key":"5819_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.12659\/AJCR.892641","volume":"16","author":"R Enr\u00edquez","year":"2015","unstructured":"Enr\u00edquez R, et al. Membranoproliferative glomerulonephritis due to visceral leishmaniasis in an HIV patient. Am J Case Rep. 2015;16:8\u201311.","journal-title":"Am J Case Rep"},{"issue":"1","key":"5819_CR10","first-page":"65","volume":"70","author":"S Alex","year":"2008","unstructured":"Alex S, et al. Nephrotic syndrome complicating chronic visceral Leishmaniasis: re-emergence in patients with AIDS. Clin Nephrol. 2008;70(1):65\u20138.","journal-title":"Clin Nephrol"},{"issue":"12","key":"5819_CR11","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S1473-3099(05)70296-6","volume":"5","author":"PL Olliaro","year":"2005","unstructured":"Olliaro PL, et al. Treatment options for visceral Leishmaniasis: a systematic review of clinical studies done in India, 1980-2004. Lancet Infect Dis. 2005;5(12):763\u201374.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"5819_CR12","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1016\/j.ijid.2008.08.011","volume":"13","author":"KP Makaritsis","year":"2009","unstructured":"Makaritsis KP, et al. Polyclonal hypergammaglobulinemia and high smooth-muscle autoantibody titers with specificity against filamentous actin: consider visceral Leishmaniasis, not just autoimmune hepatitis. Int J Infect Dis. 2009;13(4):e157\u201360.","journal-title":"Int J Infect Dis"},{"issue":"11","key":"5819_CR13","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1016\/j.celrep.2016.05.028","volume":"15","author":"S Silva-Barrios","year":"2016","unstructured":"Silva-Barrios S, et al. Innate immune B cell activation by Leishmania donovani exacerbates disease and mediates Hypergammaglobulinemia. Cell Rep. 2016;15(11):2427\u201337.","journal-title":"Cell Rep"},{"issue":"3","key":"5819_CR14","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1365-2249.1992.tb03007.x","volume":"87","author":"A Sartori","year":"1992","unstructured":"Sartori A, et al. Immune complex glomerulonephritis in experimental kala-azar. II: detection and characterization of parasite antigens and antibodies eluted from kidneys of Leishmania donovani-infected hamsters. Clin Exp Immunol. 1992;87(3):386\u201392.","journal-title":"Clin Exp Immunol"},{"issue":"Suppl 1","key":"5819_CR15","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1038\/ncpcardio0806","volume":"5","author":"J Galle","year":"2008","unstructured":"Galle J. Reduction of proteinuria with angiotensin receptor blockers. Nat Clin Pract Cardiovasc Med. 2008;5(Suppl 1):S36\u201343.","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"9","key":"5819_CR16","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/psp4.12224","volume":"6","author":"JT Ryman","year":"2017","unstructured":"Ryman JT, Meibohm B. Pharmacokinetics of monoclonal antibodies. CPT Pharmacometrics Syst Pharmacol. 2017;6(9):576\u201388.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"1\u20132","key":"5819_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S1359-6446(05)03638-X","volume":"11","author":"MA Tabrizi","year":"2006","unstructured":"Tabrizi MA, Tseng CM, Roskos LK. Elimination mechanisms of therapeutic monoclonal antibodies. Drug Discov Today. 2006;11(1\u20132):81\u20138.","journal-title":"Drug Discov Today"},{"issue":"8","key":"5819_CR18","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1172\/JCI107023","volume":"51","author":"TA Waldmann","year":"1972","unstructured":"Waldmann TA, Strober W, Mogielnicki RP. The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia. J Clin Invest. 1972;51(8):2162\u201374.","journal-title":"J Clin Invest"},{"issue":"6","key":"5819_CR19","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1046\/j.1523-1755.1998.00905.x","volume":"53","author":"C Zoja","year":"1998","unstructured":"Zoja C, et al. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. Kidney Int. 1998;53(6):1608\u201315.","journal-title":"Kidney Int"},{"issue":"4","key":"5819_CR20","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1159\/000324914","volume":"33","author":"EF Daher","year":"2011","unstructured":"Daher EF, et al. Renal function improvement with pentavalent antimonial agents in patients with visceral Leishmaniasis. Am J Nephrol. 2011;33(4):332\u20136.","journal-title":"Am J Nephrol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-05819-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-021-05819-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-05819-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T19:03:49Z","timestamp":1670958229000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-05819-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,28]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5819"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-05819-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,28]]},"assertion":[{"value":"5 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from this case report and any accompanying. If required, a copy is available to the journal in mandarin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}